Blog
본문 바로가기
메인메뉴
Company
About Qurient
History
Management
Contact Us
Business Philosophy
Pipeline
Pipeline
Adrixetinib (Q702)
Q901
Q301
Telacebec (Q203)
5-Lipoxygenase Inhibitor
Clinical Trials
Clinical Trials
IR / PR
Notice
Press Release
Qurient in the news
Financial
Disclosure
Blog
WEBTOON
WEBTOON
Company
Pipeline
Clinical Trials
IR / PR
WEBTOON
Notice
Press Release
Qurient in the news
Financial
Disclosure
Blog
Blog
게시물 검색
검색대상
title
contents
title+contents
검색어
필수
Blog 목록
Num.
Title
Author
Date
Views
1
텔라세벡 기술이전의 의미
QURIENT
2023-02-03
3996
최근 페이지로
1
페이지
2
페이지
열린
3
페이지
information for download file
* Name
Company
Phone
* Business e-mail
Comment
Request Download
팝업 닫기
Blog